These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9414105)

  • 1. The rate-limiting steps for the folding of an antibody scFv fragment.
    Jäger M; Plückthun A
    FEBS Lett; 1997 Nov; 418(1-2):106-10. PubMed ID: 9414105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folding and assembly of an antibody Fv fragment, a heterodimer stabilized by antigen.
    Jäger M; Plückthun A
    J Mol Biol; 1999 Feb; 285(5):2005-19. PubMed ID: 9925781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The scFv fragment of the antibody hu4D5-8: evidence for early premature domain interaction in refolding.
    Jäger M; Gehrig P; Plückthun A
    J Mol Biol; 2001 Feb; 305(5):1111-29. PubMed ID: 11162118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct evidence by H/D exchange and ESI-MS for transient unproductive domain interaction in the refolding of an antibody scFv fragment.
    Jäger M; Plückthun A
    Protein Sci; 2000 Mar; 9(3):552-63. PubMed ID: 10752617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of antibody chains at different stages of folding: prolyl isomerization occurs after formation of quaternary structure.
    Lilie H; Rudolph R; Buchner J
    J Mol Biol; 1995 Apr; 248(1):190-201. PubMed ID: 7731044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parallel pathways in the folding of a short-term denatured scFv fragment of an antibody.
    Freund C; Gehrig P; Baici A; Holak TA; Plückthun A
    Fold Des; 1998; 3(1):39-49. PubMed ID: 9502319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Domain interactions in antibody Fv and scFv fragments: effects on unfolding kinetics and equilibria.
    Jäger M; Plückthun A
    FEBS Lett; 1999 Dec; 462(3):307-12. PubMed ID: 10622716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Removal of the conserved disulfide bridges from the scFv fragment of an antibody: effects on folding kinetics and aggregation.
    Ramm K; Gehrig P; Plückthun A
    J Mol Biol; 1999 Jul; 290(2):535-46. PubMed ID: 10390351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic mechanism and catalysis of a native-state prolyl isomerization reaction.
    Pappenberger G; Bachmann A; Müller R; Aygün H; Engels JW; Kiefhaber T
    J Mol Biol; 2003 Feb; 326(1):235-46. PubMed ID: 12547205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability.
    Wörn A; Plückthun A
    Biochemistry; 1998 Sep; 37(38):13120-7. PubMed ID: 9748318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.
    Tan PH; Sandmaier BM; Stayton PS
    Biophys J; 1998 Sep; 75(3):1473-82. PubMed ID: 9726949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folding and association of the antibody domain CH3: prolyl isomerization preceeds dimerization.
    Thies MJ; Mayer J; Augustine JG; Frederick CA; Lilie H; Buchner J
    J Mol Biol; 1999 Oct; 293(1):67-79. PubMed ID: 10512716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic models for unfolding and refolding of ribonuclease T1 with substitution of cis-proline 39 by alanine.
    Mayr LM; Schmid FX
    J Mol Biol; 1993 Jun; 231(3):913-26. PubMed ID: 8515460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalysis of protein folding by prolyl isomerase.
    Lang K; Schmid FX; Fischer G
    Nature; 1987 Sep 17-23; 329(6136):268-70. PubMed ID: 3306408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rate of isomerisation of peptidyl-proline bonds as a probe for interactions in the physiological denatured state of chymotrypsin inhibitor 2.
    Tan YJ; Oliveberg M; Otzen DE; Fersht AR
    J Mol Biol; 1997 Jun; 269(4):611-22. PubMed ID: 9217264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular determinants of a native-state prolyl isomerization.
    Jakob RP; Schmid FX
    J Mol Biol; 2009 Apr; 387(4):1017-31. PubMed ID: 19232524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folding nuclei of the scFv fragment of an antibody.
    Freund C; Honegger A; Hunziker P; Holak TA; Plückthun A
    Biochemistry; 1996 Jun; 35(25):8457-64. PubMed ID: 8679604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment.
    Arndt KM; Müller KM; Plückthun A
    Biochemistry; 1998 Sep; 37(37):12918-26. PubMed ID: 9737871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disrupting the hydrophobic patches at the antibody variable/constant domain interface: improved in vivo folding and physical characterization of an engineered scFv fragment.
    Nieba L; Honegger A; Krebber C; Plückthun A
    Protein Eng; 1997 Apr; 10(4):435-44. PubMed ID: 9194169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A kinetic trap is an intrinsic feature in the folding pathway of single-chain Fv fragments.
    Hoyer W; Ramm K; Plückthun A
    Biophys Chem; 2002 May; 96(2-3):273-84. PubMed ID: 12034446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.